A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine
Email
Print
Home > Medical Reference > Encyclopedia (English)
Toggle: English / SpanishDisplasia cervical - Symptom
Nombres alternativos
Cambios precancerosos del cuello uterino; Neoplasia intraepitelial cervical (NIC)
Síntomas:
Generalmente no hay síntomas.
Pruebas y exámenes:
Un examen pélvico generalmente es normal.
La displasia que se observa en una citología vaginal se denomina lesión escamosa intraepitelial (LEI). Estos cambios se pueden clasificar como:
- De bajo grado (LEIBG).
- De alto grado (LEIAG).
- Posiblemente cancerosos (malignos).
Si una citología vaginal muestra células anormales o displasia cervical, se recomendarán pruebas adicionales o monitoreo.
- Se pueden recomendar citologías de control para casos leves.
- Una biopsia dirigida por colposcopia puede confirmar la afección.
- Una conización quirúrgica se puede hacer después de la colposcopia.
La displasia que se observa en una biopsia del cuello uterino se denomina neoplasia intraepitelial cervical (NIC) y se agrupa en tres categorías:
- NIC I: displasia leve.
- NIC II: displasia moderada a acentuada.
- NIC III: displasia severa a carcinoma in situ.
Se sabe que algunas cepas del virus del papiloma humano (VPH) causan cáncer del cuello uterino. Con un examen de ADN para el VPH, se pueden identificar los tipos de VPH de alto riesgo ligados a dicho cáncer. Esto se puede hacer:
- Como una prueba de detección para mujeres de más de 30 años.
- Para mujeres de cualquier edad que tengan un resultado ligeramente anormal en su citología vaginal.
- Reviewed last on: 2/28/2011
- Linda J. Vorvick, MD, Medical Director, MEDEX Northwest Division of Physician Assistant Studies, University of Washington, School of Medicine; Susan Storck, MD, FACOG, Chief, Eastside Department of Obstetrics and Gynecology, Group Health Cooperative of Puget Sound, Bellevue, Washington; Clinical Teaching Faculty, Department of Obstetrics and Gynecology, University of Washington School of Medicine. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
Referencias
Cervical cancer in adolescents: screening, evaluation, and manage- ment. Committee Opinion No. 463. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2010;116:469–72.
ACOG Practice Bulletin No. 99: management of abnormal cervical cytology and histology. Obstet Gynecol. 2008;112(6):1419-1444.
Wright TC Jr, Massad LS, Dunton CJ, et al. American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference: 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcihnoma in situ. Am J Obstet Gynecol. 2007;197(4):340-345.
Wright TC Jr, Massad LS, Dunton CJ, et al. American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference: 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol. 2007;197(4):346-355.
Kahn JA. HPV vaccination for the prevention of cervical intraepithelial neoplasia. N Engl J Med. 2009;361:271-278.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
Click to Print
Print Preview
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885
